The Senate Commerce Committee today held a hearing in which members on both sides of the aisle raised questions about the practices of pharmaceutical middlemen, known as pharmacy benefit managers, or PBMs.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,